Radiation therapy to the prostate involves increasingly sophisticated delivery techniques
and changing fractionation schedules. With a low estimated α/β ratio, a larger dose per …

Purpose To review and analyze the published data on high-dose-rate brachytherapy as
monotherapy in the treatment of prostate cancer. Methods A literature search and a …

Abstract Background and Purpose High dose-rate (HDR) brachytherapy as a monotherapy
is an accepted treatment for localized prostate cancer, but the optimal dose and fractionation …

Purpose High-dose-rate (HDR) brachytherapy was originally used with external beam
radiation therapy (EBRT) to increase the dose to the prostate without injuring the bladder or …

Background and purpose Multi-fraction high dose-rate (HDR) brachytherapy as
monotherapy is safe and effective for low and intermediate risk prostate cancer. Two or …

Background To evaluate acute and late genitourinary, the gastrointestinal toxicity and the
long-term biochemical control after HDR monotherapy in one fraction (19 Gy). Patients and …

Purpose We report the outcomes associated with 3 high-dose-rate (HDR) brachytherapy
regimens used as monotherapy for favorable-risk prostate cancer. Methods and Materials …

Context Harmonisation of outcome reporting and definitions for clinical trials and routine
patient records can enable health care systems to provide more efficient outcome-driven …

Purpose To evaluate acute and late genitourinary toxicity, the gastrointestinal toxicity, and
the long-term biochemical control after high-dose-rate (HDR) monotherapy in one fraction …

Background Single-dose high-dose-rate brachytherapy (HDR-BT), in a Phase-II study, was
compared to two or three fractions in intermediate and high-risk localized prostate cancer …